helospectin I
Names
[ CAS No. ]:
93438-37-0
[ Name ]:
helospectin I
Biological Activity
[Description]:
Helospectin I is a neuropeptide of the vasoactive intestinal peptide (VIP) family. Helospectin I has vasodilatory and antihypertensive activities, and decreases blood pressure. Helospectin I is originally isolated from the salivary gland venom of the lizard Heloderma suspectum[1][2].
[Related Catalog]:
[Target]
Vasoactive intestinal peptide (VIP)[1]
[In Vitro]
Helospectin I (suffusion at 0.1 nM, in bicarbonate buffer for 30 min) evokes significant, sustained and similar vasodilation in the intact hamster cheek pouch[1]. Helospectin I relaxes the Phenylephrine-contracted rat femoral arteries with pEC50 of 6.82[2]. Helospectin I (0.1 nM-1 μM) inhibits the binding of 125I-labeled VIP and 125I-secretin to dispersed chief cells[4].
[In Vivo]
Helospectin I (0.03-2 nmol/kg, 100 μL of infusion at the left jugular vein) reduces blood pressure in rats[2]. Helospectin I (0.1-0.8 nmol /kg, i.v.) increases plasma levels of glucagon in mice[3]. Animal Model: SD rats[2] Dosage: 0.03, 0.3, 1, 2 nM/kg Administration: 100 μL of infusion at the left jugular vein, followed by washing the catheter with 100 μL saline. Result: Reduced the blood pressure, but was less effective than vasoactive intestinal peptide (VIP) in the low dose range. Animal Model: Mice[3] Dosage: 0.1, 0.2, 0.4, 0.8 nM /kg Administration: Intravenous injection (i.v.) Result: Markedly stimulated glucagon secretion, and had no direct action on insulin secretion.
[References]
Chemical & Physical Properties
[ Molecular Formula ]:
C183H293N47O59